TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal (SONDALIS)
Sponsor: Société des Produits Nestlé (SPN)
Terminated
The study has been stopped prematurely for lack of inclusions
Other terminated trials from Société des Produits Nestlé (SPN)
Other Malnutrition trials with similar outcome
This NA trial investigates Malnutrition and is currently terminated or withdrawn. Société des Produits Nestlé (SPN) leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Terminated NA
Status: Unknown → Terminated
-
Nov 2025 — Jan 2026 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Mar 2023 — Jan 2024 [monthly]
Recruiting NA
-
Sep 2022 — Mar 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Société des Produits Nestlé (SPN)
For direct contact, visit the study record on ClinicalTrials.gov .